373
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Association of TMEM132D, COMT, and GABRA6 genotypes with cingulate, frontal cortex and hippocampal emotional processing in panic and major depressive disorder

, , , , , , , , , , , & show all
Pages 192-200 | Received 13 Sep 2014, Accepted 15 Apr 2015, Published online: 14 May 2015

References

  • Annerbrink K, Westberg L, Olsson M, Allgulander C, Andersch S, Sjödin I, et al. 2010. Association between the catechol-O-methyltransferase Val158Met polymorphism and panic disorder: a replication. Psychiatry Res 178:196–198.
  • Arias B, Serretti A, Lorenzi C, Gasto C, Catalan R, Fananas L. 2006. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J Affect Disord 90:251–256.
  • Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, Roehrs T, et al. 2008. Association of the COMT Val158Met Variant with Antidepressant Treatment Response in Major Depression. Neuropsychopharmacology 33:924–932.
  • Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, et al. 2011. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16:516–532.
  • Coplan JD, Lydiard RB. 1998. Brain circuits in panic disorder. Biol Psychiatry 44:1264–1276.
  • Domschke K, Freitag CM, Kuhlenbäumer G, Schirmacher A, Sand P, Nyhuis P, et al. 2004. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 7:183–188.
  • Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C, et al. 2008. Influence of the catechol-O-methyltransferase Val158Met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163:13–20.
  • Domschke K, Dannlowski U. 2010. Imaging genetics of anxiety disorders. Neuroimage 53:822–831.
  • Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, et al. 2006. Catechol O-methyltransferase Val158Met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 63:1396–1406.
  • Dratcu L. 2000. Panic, hyperventilation and perpetuation of anxiety. Prog Neuro Psychopharmacol Biol Psychiatry 24:1069–1089.
  • Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH. 2013. Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 147:1–13.
  • Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, et al. 2010. TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 16: 647–663.
  • Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Müller-Myhsok B, et al. 2012. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry 2:e156.
  • Etkin A, Wager TD. 2007. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164:1476–1488.
  • Fox CJ, Iaria G, Barton JJS. 2009. Defining the face processing network: optimization of the functional localizer in fMRI. Hum Brain Mapp 30:1637–1651.
  • Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E, et al. 1999. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry 4:389–392.
  • Fu CH, Williams SC, Brammer MJ, Suckling J, Kim J, Cleare AJ, et al. 2007. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry 164: 599–607
  • Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, et al. 2005. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1:19.
  • Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, et al. 2006. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:363–374.
  • Gregersen NO, Buttenschøn HN, Hedemand A, Dahl HA, Kristensen AS, Clementsen B, et al. 2014. Are TMEM genes potential candidate genes for panic disorder? Psychiatr Genet 24:37–41.
  • Haaker J, Lonsdorf TB, Raczka KA, Mechias ML, Gartmann N, Kalisch R. 2014. Higher anxiety and larger amygdala volumes in carriers of a TMEM132D risk variant for panic disorder. Transl Psychiatry 4:e357.
  • Halleland H, Lindervold AJ, Halmoy A, Haavik J, Johansson S. 2009. Association between Catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in Adults . Am J Med Genet 150B:403–410.
  • Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF, et al. 2002. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 51:591–601.
  • Hamilton SP. 2009. Linkage and association studies of anxiety disorders. Depress Anxiety 26:976–983.
  • Hamon M, Blier P. 2013. Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry 45:54–63.
  • Hasler G, Fromm S, Alvarez RP, Luckenbaugh DA, Drevets WC, Grillon C. 2007. Cerebral blood flow in immediate and sustained anxiety. J Neurosci 27:6313–6319.
  • Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568–1578.
  • Hosák L. 2007. Role of COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry 22:276–281.
  • Hosák L, Hosáková J. 2010. Genetics of the Human Personality. Act Nerv Super Rediviva 52:18–27.
  • Ji Y, Biernacka J, Snyder K, Drews M, Pelleymounter LL, Colby C, et al. 2012. Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response. Pharmacogenomics 12:78–85.
  • Kalueff AV, Nutt DJ. 2007. Role of GABA in anxiety and depression. Depress Anxiety 24: 495–517.
  • Karege F, Bovier P, Gaillard JM, Tissot R. 1987. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr Scand 76:303–308.
  • Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J, Collier D, et al. 2009. The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study. Int J Neuropsychopharmacol 12:371–381.
  • Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2006. A Swedish national twin study of lifetime major depression. Am J Psychiatry 163:109–114.
  • Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. 2003. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105.
  • Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. 2006. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63:415–424.
  • Kobayashi Y, Akiyoshi J, Kanehisa M, Ichioka S, Tanaka Y, Tsuru J, et al. 2007. Lack of polymorphism in genes encoding mGluR 7, mGluR 8, GABA(A) receptor alfa-6 subunit and nociceptin/orphanin FQ receptor and panic disorder. Psychiatr Genet 17:9.
  • Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, et al. 2010. The impact of catechol-Omethyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Int Clin Psychopharmacol 25:218–227.
  • Konneker T, Barnes T, Furberg H, Losh M, Bulik CM, Sullivan PF. 2008. A searchable database of genetic evidence for psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 147B: 671–675.
  • Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, et al. 1997. No evidence for an association of affective disorders with high- or low-activity allele of catechol-Omethyltransferase gene. Biol Psychiatry 42:282–285.
  • Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshiboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250.
  • Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P, Powell J, et al. 2011. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol Med 41:779–788.
  • Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, et al. 2010. Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 167:949–957.
  • Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis (http://analysis.bio-x.cn). Cell Res 19:519–523.
  • Lonsdorf TB, Golkar A, Lindstöm KM, Fransson P, Schalling M, Ohman A, et al. 2011. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity andhabituation. Biol Psychol 87:106–112.
  • Mahon K, Burdick KE, Szeszko PR. 2010. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev 34:533–554.
  • Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, et al. 2005. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry 10:598–605.
  • Massat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, et al. 2011. COMT and age at onset in mood disorders: a replication and extension study. Neurosci Lett 498:218–221.
  • Michaelovsky E, Gothelf D, Korostishevsky M, Frisch A, Burg M, Carmel M, et al. 2008. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. Int J Neuropsychopharmacol 11:351–363.
  • Mier D, Kirsch P, Meyer-Lindenberg A. 2010. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 15:918–927.
  • Milad MR, Quirk GJ, Pitman RK, Orr SP, Fischl B, Rauch SL. 2007. A role for the human dorsal anterior cingulate cortex in fear expression. Biol Psychiatry 62:1191–1194.
  • Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B, et al. 2007. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 317(5841):1079–1083.
  • Moriguchi Y, Ohnishi T, Kawachi T, Mori T, Hirakata M, Yamada M, et al. 2005. Specific brain activation in Japanese and Caucasian people to fearful faces. NeuroReport 16:133–136.
  • Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, et al. 2010. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 15:589–601.
  • Muiños-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipilä T, Maron E, et al. 2011. Human microRNAs miR-22, miR-138–2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 69:526–533.
  • Nomoto H, Yonezawa T, Itoh K, Ono K, Yamamoto K, Oohashi T et al. 2003. Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. J Biochem 134: 231–238.
  • Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K. 1998. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Research 80(2):145–148.
  • Ohman A. 2005. The role of the amygdala in human fear: automatic detection of threat. Psychoneuroendocrinology 30:953–958.
  • Opmeer EM, Kortekaas R, van Tol MJ, van der Wee NJ, Woudstra S, van Buchem MA, et al. 2013. Influence of COMT val158met genotype on the depressed brain during emotional processing and working memory. PLoS One 8:e73290.
  • Persad SM, Polivy J. 1993. Differences between depressed and nondepressed individuals in the recognition of and response to facial emotional cues. J Abnorm Psychol 102:358–368.
  • Pitcher D, Walsh V, Duchaine B. 2011. The role of the occipital face area in the cortical face perception network. Exp Brain Res 209:481–493.
  • Preter M, Klein DF. 2008. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuro-Psychopharmacol Biol Psychiatry 32:603–612.
  • Prochnow D, Kossack H, Brunheim S, Müller K, Wittsack HJ, Markowitsch HJ, et al. 2013. Processing of subliminal facial expressions of emotion: a behavioral and fMRI study. Soc Neurosci 8: 448–461.
  • Quast C, Altmann A, Weber P, Arloth J, Bader D, Heck A, et al. 2012. Rare variants in TMEM132D in a case-control sample for panic disorder. Am J Med Genet B Neuropsychiatr Genet 159B:896–907.
  • Rasch B, Spalek K, Buholzer S, Luechinger R, Boesiger P, de Quervain DJ, et al. 2010. Aversive stimuli lead to differential amygdala activation and connectivity patterns depending on catechol-O-methyltransferase Val158Met genotype. Neuroimage 52:1712–1719.
  • Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, et al. 2006. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 31:2237–2242.
  • Rotondo A, Mazzanti C, Dell’Osso L, Rucci P, Sullivan P, Bouanani S, et al. 2002. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 159:23–29.
  • Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepień G, Grzywacz A, et al. 2004. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res 128:21–26.
  • Savitz JB, Ramesar RS. 2004. Genetic variants implicated in personality: a review of the more promising candidates. Am J Med Genet B Neuropsychiatr Genet 131B:20–32.
  • Scharinger C, Rabl U, Sitte HH, Pezawas L. 2010. Imaging genetics of mood disorders. Neuroimage 53:810–821.
  • Sen S, Villafuerte S, Nesse R, Stoltenberg SF, Hopcian J, Gleiberman L, et al. 2004. Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism. Biol Psychiatry 55:244–249.
  • Serretti A, Cusin C, Cristina S, Lorenzi C, Lilli R, Lattuada E, et al. 2003. Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders. Psychiatric Genet 13:121–126.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33.
  • Shi YY, He L. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research 15:97–98.
  • Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. 2004. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Molecular Psychiatry 9:151–160.
  • Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weinzman A, et al. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296–1302.
  • Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H, Mann K, et al. 2005. Catechol-O-methyltransferase Val158Met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25:836–842.
  • Smolka MN, Bühler M, Schumann G, Klein S, Hu XZ, Moayer M, et al. 2007. Gene–gene effects on central processing of aversive stimuli. Mol Psychiatry 12:307–317.
  • Speilberger CD, Edwards CD, Lushene RE, Montuori J, Platzek D. 1973. State-Trait Anxiety Inventory for Children: Professional manual. Redwood City, CA: Mind Garden, Inc.
  • Straube T, Mentzel HJ, Miltner WH. 2007. Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage 37:1427–1436.
  • Tham MW, Woon PS, Sum MY, Lee TS, Sim K. 2011. White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies. J Affect Disord 132:26–36.
  • Szegedi A, Rujescu D, Tadic A, Müller MJ, Kohnen R, Stassen HH, et al. 2005. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics J 5:49–53.
  • Uhart M, McCaul ME, Oswald LM, Choi L, Wand GS. 2004. GABRA6 gene polymorphism and an attenuated stress response. Mol Psychiatry 9:998–1006.
  • Weiss EM, Stadelmann E, Kohler CG, Brensinger CM, Nolan KA, Oberacher H, et al. 2007. Differential effect of catechol-O-methyltransferase Val158-Met genotype on emotional recognition abilities in healthy men and women. J Int Neuropsychol Soc 13:881–887.
  • Williams LM, Gatt JM, Grieve SM, Dobson-Stone C, Paul RH, Gordon E, et al. 2010. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Neuroimage 53:918–925.
  • Woo JM, Yoon KS, Yu BH. 2002. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 159:1785–1787.
  • Woo JM, Yoon KS, Choi YH, Oh KS, Lee YS, Yu BH. 2004. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J Psychiatr Res 38:365–370.
  • Wray NR, James MR, Dumenil T, Handoko HY, Lind PA, Montgomery GW, et al. 2008. Association study of candidate variants of COMT with neuroticism, anxiety and depression. Am J Med Genet Neuropsychiatr Genet 147B:1314–1318.
  • Yeragani VK, Nadella R, Hinze B, Yeragani S, Jampala VC. 2000. Nonlinear measures of heart period variability: decreased measures of symbolic dynamics in patients with panic disorder. Depression and Anxiety 12:67–77.
  • Zintzaras E, Sakelaridis N. 2007. Is 472 G/A catechol-O-methyl-transferase gene polymorphism related to panic disorder? Psychiatric Genetics 17:267–273.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.